Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseasesRenaud Felten, Laurent Arnaud, Jérémy Fort et al.|The Lancet Rheumatology|2021Cited by 125
Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseasesRenaud Felten, Laurent Arnaud, Maxime Dubois et al.|Lara D. Veeken|2021Cited by 29
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)Jacques‐Eric Gottenberg, Xavier Mariette, Aurore Chaudier et al.|RMD Open|2022Cited by 4
POS1190 EXPECTATIONS AND POTENTIAL CONCERNS OF PATIENTS WITH AUTOIMMUNE AND RHEUMATIC DISEASES REGARDING VACCINATION AGAINST SARS-CoV-2 (COVID-19): THE WORLDWIDE ONLINE VAXICOV STUDYRenaud Felten, Laurent Arnaud, Maxime Dubois et al.|Annals of the Rheumatic Diseases|2021Cited by 2